Cargando…

Correction: (18)F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Grimmer, Timo, Shi, Kuangyu, Diehl-Schmid, Janine, Natale, Bianca, Drzezga, Alexander, Förster, Stefan, Förstl, Hans, Schwaiger, Markus, Yakushev, Igor, Wester, Hans-Jürgen, Kurz, Alexander, Yousefi, Behrooz Hooshyar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608368/ https://www.ncbi.nlm.nih.gov/pubmed/30464328 http://dx.doi.org/10.1038/s41380-018-0302-3

Ejemplares similares

FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice
por: Yousefi, Behrooz H, et al.
Publicado: (2015)

LRP-1 polymorphism is associated with global and regional amyloid load in Alzheimer's disease in humans in-vivo
por: Grimmer, Timo, et al.
Publicado: (2014)

Cerebrospinal Fluid BACE1 Activity and Brain Amyloid Load in Alzheimer's Disease
por: Grimmer, Timo, et al.
Publicado: (2012)

Cerebrospinal fluid biomarkers for Alzheimer’s disease: the role of apolipoprotein E genotype, age, and sex
por: Mehrabian, Shima, et al.
Publicado: (2015)

Correction to: Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2020)

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer’s disease
por: Ortner, Marion, et al.
Publicado: (2019)

Progressively Disrupted Intrinsic Functional Connectivity of Basolateral Amygdala in Very Early Alzheimer’s Disease
por: Ortner, Marion, et al.
Publicado: (2016)

Frontotemporal lobar degeneration: current perspectives
por: Riedl, Lina, et al.
Publicado: (2014)

Synthesis and preclinical evaluation of novel (18)F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with (18)F-DCFPyl and (18)F-PSMA-1007
por: Robu, Stephanie, et al.
Publicado: (2018)

Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
por: Hedderich, Dennis M., et al.
Publicado: (2020)

Decreased Vascular Pulsatility in Alzheimer’s Disease Dementia Measured by Transcranial Color-Coded Duplex Sonography
por: Ortner, Marion, et al.
Publicado: (2019)

Impaired Cross-Modal Inhibition in Alzheimer Disease
por: Drzezga, Alexander, et al.
Publicado: (2005)

Elecsys Cerebrospinal Fluid Immunoassays Accurately Detect Alzheimer’s Disease Regardless of Concomitant Small Vessel Disease
por: Ortner, Marion, et al.
Publicado: (2023)

Within-patient correspondence of amyloid-β and intrinsic network connectivity in Alzheimer’s disease
por: Myers, Nicholas, et al.
Publicado: (2014)

Mapping covariance in brain FDG uptake to structural connectivity
por: Yakushev, Igor, et al.
Publicado: (2021)

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer’s Disease
por: Li, Rui, et al.
Publicado: (2015)

Mapping the Binding Interface of PET Tracer Molecules and Alzheimer Disease Aβ Fibrils by Using MAS Solid‐State NMR Spectroscopy
por: Niu, Zheng, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
por: Ortner, Marion, et al.
Publicado: (2020)

Reference Cluster Normalization Improves Detection of Frontotemporal Lobar Degeneration by Means of FDG-PET
por: Dukart, Juergen, et al.
Publicado: (2013)

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels
por: Ortner, Marion, et al.
Publicado: (2020)

Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET
por: Goldhardt, Oliver, et al.
Publicado: (2019)

The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort
por: Amft, Michaela, et al.
Publicado: (2022)

Small-Animal PET Imaging of Amyloid-Beta Plaques with [(11)C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
por: Manook, André, et al.
Publicado: (2012)

FDG-PET underscores the key role of the thalamus in frontotemporal lobar degeneration caused by C9ORF72 mutations
por: Diehl-Schmid, Janine, et al.
Publicado: (2019)

Disease specific and nonspecific metabolic brain networks in behavioral variant of frontotemporal dementia
por: Rus, Tomaž, et al.
Publicado: (2022)

PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape
por: Uzuegbunam, Bright Chukwunwike, et al.
Publicado: (2020)

A multivariate metabolic imaging marker for behavioral variant frontotemporal dementia
por: Nazem, Amir, et al.
Publicado: (2018)

Altered neurovascular coupling as measured by optical imaging: a biomarker for Alzheimer’s disease
por: Kotliar, Konstantin, et al.
Publicado: (2017)

Toward Novel [(18)F]Fluorine-Labeled Radiotracers for the Imaging of α-Synuclein Fibrils
por: Uzuegbunam, Bright C., et al.
Publicado: (2022)

In Silico and In Vitro Study towards the Rational Design of 4,4′-Disarylbisthiazoles as a Selective α-Synucleinopathy Biomarker
por: Uzuegbunam, Bright C., et al.
Publicado: (2023)

Impact of normative brain volume reports on the diagnosis of neurodegenerative dementia disorders in neuroradiology: A real-world, clinical practice study
por: Hedderich, Dennis M., et al.
Publicado: (2022)

Step by Step: Kinematics of the Reciprocal Trail Making Task Predict Slowness of Activities of Daily Living Performance in Alzheimer’s Disease
por: Gulde, Philipp, et al.
Publicado: (2018)

An Explorative Note on Apraxia Tests
por: Gulde, Philipp, et al.
Publicado: (2018)

Perceived Need and Acceptability of an App to Support Activities of Daily Living in People With Cognitive Impairment and Their Carers: Pilot Survey Study
por: Lai, Rhoda, et al.
Publicado: (2020)

Cerebrospinal fluid lactate levels along the Alzheimer’s disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers
por: Zebhauser, Paul Theo, et al.
Publicado: (2022)

A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency
por: Osl, Theresa, et al.
Publicado: (2020)

IssuEs in Palliative care for people in advanced and terminal stages of Young-onset and Late-Onset dementia in GErmany (EPYLOGE): the study protocol
por: Diehl-Schmid, Janine, et al.
Publicado: (2018)

Comparison of (18)F-T807 and (18)F-THK5117 PET in a Mouse Model of Tau Pathology
por: Brendel, Matthias, et al.
Publicado: (2018)

Neuronavigated repetitive transcranial magnetic stimulation as novel mapping technique provides insights into language function in primary progressive aphasia
por: Mueller-Sarnowski, Felix, et al.
Publicado: (2021)

Olga von Leonowa (1851–?): eine Neurowissenschaftlerin verschwindet
por: Förstl, Hans
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jg75t9fn0apokoua1uecgjqm0h